Ricerca
I test allergologici nella diagnosi di ipersensibilità all’amoxicillina nel bambino
Allergologic work-up in diagnosing amoxicillin hypersensivity in children
F. Tubili, C. Angelucci, D. Butti, S. Barni, F. Mori, E. Novembre
Settembre 2013 - pagg. 446 -452
Abstract
Introduction - Adverse reactions to antibiotics, in particular to Amoxicillin, are frequently
reported by parents but the allergologic work-up confirms a true state of drug hypersensitivity
only in a small percentage of cases.
Objective - The aim of this study was to evaluate the utility of the skin tests methods and of the specific serum IgE assays in the diagnosis of mild-moderate Amoxicillin hypersensitivity reactions in children.
Materials and methods - 52 children (mean age 7.48 years) with history of mild-moderate cutaneous adverse reactions following the ingestion of Amoxicillin syrup were examined; the clinical manifestations of hypersensitivity were classified as immediate and non immediate according to the timing of the reaction (within 1 hour and after 1 hour from the last drug intake, respectively). Patients underwent skin tests (Skin Prick Test and Intradermal Test), determination of total and specific serum IgE with an immunoassay method (UNICAP) and with the epoxy-activated sepharose 6 B radioimmunoassay. All children underwent the Oral Provocation Test (OPT) with Amoxicillin.
Results - 13/52 (25%) and 39/52 (75%) children had history of immediate and non immediate reactions to Amoxicillin, respectively. The OPT resulted positive in 2 out of 13 (15.4%) and in 5 out of 39 (12.8%) of patients with history of immediate and non immediate reactions, respectively. In 3 children with history of immediate reactions, Amoxicillin specific serum IgE were detected by skin tests or in vitro tests and among them only one child had a positive OPT. None of those 32 subjects with history of non immediate reactions, who took the skin tests, had a positive response to immediate reading of the intradermal test, whereas one child had a positive delayed intradermal response. 6 out of 39 children with history of non immediate reactions had specific serum IgE; it was shown by the epoxy-activated method and among them 3 children had also a positive OPT. None of the 39 subjects had positive results with the UNICAP. All OPT-positive subjects showed mild skin reactions.
Conclusions - The present study highlights the weak utility of the in vivo and in vitro tests in the diagnosis of non immediate Amoxicillin hypersensitivity reactions and on the other hand, it emphasizes the importance and the relative safety of the OPT.
Objective - The aim of this study was to evaluate the utility of the skin tests methods and of the specific serum IgE assays in the diagnosis of mild-moderate Amoxicillin hypersensitivity reactions in children.
Materials and methods - 52 children (mean age 7.48 years) with history of mild-moderate cutaneous adverse reactions following the ingestion of Amoxicillin syrup were examined; the clinical manifestations of hypersensitivity were classified as immediate and non immediate according to the timing of the reaction (within 1 hour and after 1 hour from the last drug intake, respectively). Patients underwent skin tests (Skin Prick Test and Intradermal Test), determination of total and specific serum IgE with an immunoassay method (UNICAP) and with the epoxy-activated sepharose 6 B radioimmunoassay. All children underwent the Oral Provocation Test (OPT) with Amoxicillin.
Results - 13/52 (25%) and 39/52 (75%) children had history of immediate and non immediate reactions to Amoxicillin, respectively. The OPT resulted positive in 2 out of 13 (15.4%) and in 5 out of 39 (12.8%) of patients with history of immediate and non immediate reactions, respectively. In 3 children with history of immediate reactions, Amoxicillin specific serum IgE were detected by skin tests or in vitro tests and among them only one child had a positive OPT. None of those 32 subjects with history of non immediate reactions, who took the skin tests, had a positive response to immediate reading of the intradermal test, whereas one child had a positive delayed intradermal response. 6 out of 39 children with history of non immediate reactions had specific serum IgE; it was shown by the epoxy-activated method and among them 3 children had also a positive OPT. None of the 39 subjects had positive results with the UNICAP. All OPT-positive subjects showed mild skin reactions.
Conclusions - The present study highlights the weak utility of the in vivo and in vitro tests in the diagnosis of non immediate Amoxicillin hypersensitivity reactions and on the other hand, it emphasizes the importance and the relative safety of the OPT.
Parole chiave
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Bousquet PJ, Demoly P, Romano A, et al;
Global Allergy, Asthma European Network
(GALEN) and Drug Allergy and Hypersensitivity
Database (DAHD) and the European
Network for Drug Allergy (ENDA). Pharma-covigilance of drug allergy and hypersensitivity
using the ENDA-DAHD database and the
GALEN platform. The Galenda project. Allergy
2009;64:194-203.
2. WHO. International drug monitoring: the
role of national centres. Tech Rep Ser 1972;
498:1-25.
3. Thong BY, Tan TC. Epidemiology and risk
factors for drug allergy. Br J Clin Pharmacol
2011;71:684-700.
4. Clavenna A, Bonati M. Adverse drug reactions
in childhood: a review of prospective
studies and safety alerts. Arch Dis Child 2009;
94:724-8.
5. Gruchalla RS. Drug Allergy. J Allergy Clin
Immunol 2003;111:S548-59.
6. Vervrolet D, Durham S. Adverse reactions
to drugs. BMJ 1998;316:1511-4.
7. Novembre E, Mugnaini L, Mori F, Rossi E,
Pucci N. Le reazioni allergiche da farmaci. Appunti
di Allergologia pediatrica. Editeam,
2009.
8. Bachot N, Roujeau JC. Differential diagnosis
of severe cutaneous drug eruptions. Am J
Clin Dermatol 2003;4:561-72.
9. Ponvert C, Perrin Y, Bados-Albiero A, et al.
Allergy to betalactam antibiotics in children:
results of a 20-year study based on clinical history,
skin and challenge tests. Pediatr Allergy
Immunol 2011;22:411-8.
10. Padial A, Antunez C, Blanca-Lopez N, et al.
Non-immediate reactions to beta-lactams: diagnostic
value of skin testing and drug provocation
test. Clin Exp Allergy 2008;38:822-8.
11. Rerkpattanapipat T, Chiriac AM, Demoly
P. Drug provocation tests in hypersensitivity
drug reactions. Curr Opin Allergy Clin Immunol
2011;11:299-304.
12. Caubet JC, Eigenmann PA. Managing possible
antibiotic allergy in children. Curr Opin
Infect Dis 2012;25(3):279-85.
13. Demoly P, Kropf R, Bircher A, Pichler WJ.
Drug hypersensitivity: questionnaire. EAACI
interest group on drug hypersensitivity. Allergy
1999;54:999-1003.
14. Romano A, Blanca M, Torres MJ, et al.;
ENDA; EAACI. Diagnosis of nonimmediate
reactions to beta-lactam antibiotics. Allergy
2004;59:1153-60.
15. Aberer W, Bircher A, Romano A, et al.; European
Network for Drug Allergy (ENDA);
EAACI interest group on drug hypersensitivity.
Drug provocation testing in the diagnosis of
drug hypersensitivity reactions: general considerations.
Allergy 2003;58:854-63.
16. Brockow K, Romano A, Blanca M, Ring J,
Pichler W, Demoly P. General considerations
for skin test procedures in the diagnosis of
drug hypersensitivity. Allergy 2002;57:45-51.
17. Chambel M, Martins P, Silva I, et al. Drug
provocation tests to betalactam antibiotics: experience
in a paediatric setting. Allergol Immunopathol
(Madr) 2010;38:300-6.
18. Vultaggio A, Matucci A, Virgili G, et al. Influence
of total serum IgE levels on the in vitro
detection of beta-lactams-specific IgE antibodies.
Clin Exp Allergy 2009;39:838-44.
19. Baldo BA, Harle DG. Drug allergenic determinants.
Monogr Allergy 1990;28:11-51.
20. Manfredi M, Severino M, Testi S, et al. Detection
of specific IgE to quinolones. J Allergy
Clin Immunol 2004;113:155-60.
21. Pham NH, Baldo BA, Manfredi M, Zerboni
R. Fine structural specificity differences of
trimethoprim allergenic determinants. Clin
Exp Allergy 1996;26:1155-60.
22. Clavenna A, Bonati M. Drug prescriptions
to outpatients children: a review of the literature.
Eur J Clin Pharmacol 2009;65:749-55.
23. Novembre E, Bernardini R, Vierucci A. Allergia
agli antibiotici in età pediatrica. Prospettive
in Pediatria 2004;34:197-206.
24. Blanca M, Torres MJ, Blanca-Lopez N,
Canto MG. Penicillin determinants in the diagnosis
of immediate hypersensitivity reactions
to -lactams. Int Arch Allergy Immunol
2011;155:187-8.
25. Blanca M, Mayorga C, Torres MJ, et al.
Clinical evaluation of Pharmacia CAP System
RAST FEIA amoxicilloyl and benzylpenicilloyl
in patients with penicillin allergy. Allergy
2001;56:862-70.
26. Zhao Z, Baldo BA, Baumgart KW, Mallon
DF. Fine structural recognition specificities of
IgE antibodies distinguishing amoxicilloyl
and amoxicillanyl determinants in allergic
subjects. J Mol Recognit 2001;14:300-7.
27. Torres MJ, Romano A, Mayorga C, et al.
Diagnostic evaluation of a large group of patients
with immediate allergy to penicillins:
the role of skin testing. Allergy 2001;56:850-6.
28. Romano A, Bousquet-Rouanet L, Viola M,
Gaeta F, Demoly P, Bousquet PJ. Benzylpenicillin
skin testing is still important in diagnosing
immediate hypersensitivity reactions to
penicillins. Allergy 2009;64:249-53.
29. Torres MJ, Ariza A, Fernández J, et al. Role
of minor determinants of amoxicillin in the
diagnosis of immediate allergic reactions to
amoxicillin. Allergy 2010;65:590-6.
30. Ponvert C, Le Clainche L, de Blic J, Le
Bourgeois M, Scheinmann P, Paupe J. Allergy
to beta-lactam antibiotics in children. Pediatrics
1999;104:e45.
31. Romano A, Gaeta F, Valluzzi RL, Alonzi C,
Viola M, Bousquet PJ. Diagnosing hypersensitivity
reactions to cephalosporins in children.
Pediatrics 2008;122:521-7.
32. Caubet JC, Kaiser L, Lemaître B, Fellay B,
Gervaix A, Eigenmann PA. The role of penicillin
in benign skin rashes in childhood: a
prospective study based on drug rechallenge.
J Allergy Clin Immunol 2011;127:218-22.
33. Na HR, Lee JM, Jung JW, Lee SY. Usefulness
of drug provocation tests in children with
a history of adverse drug reaction. Korean J
Pediatr 2011;54:304-9.
34. Moral L, Garde J, Toral T, Fuentes MJ,
Marco N. Short protocol for the study of paediatric
patients with suspected betalactam antibiotic
hypersensitivity and low risk criteria.
Allergol Immunopathol (Madr) 2011;39:337-
41.
35. Torres MJ, Blanca M, Fernandez J, et al.;
ENDA; EAACI Interest Group on Drug Hypersensitivity.
Diagnosis of immediate allergic
reactions to beta-lactam antibiotics. Allergy
2003;58:961-72.
36. Messaad D, Sahla H, Benahmed S, Godard
P, Bousquet J, Demoly P. Drug provocation
tests in patients with a history suggesting an
immediate drug hypersensitivity reaction.
Ann Intern Med 2004;140:1001-6.
37. Blanca M, Mayorga C, Torres MJ, et al.
Clinical evaluation of Pharmacia CAP System
RAST FEIA amoxicilloyl and benzylpenicilloyl
in patients with penicillin allergy. Allergy 2001;
56:862-70.
38. Fontaine C, Mayorga C, Bousquet PJ, et
al. Relevance of the determination of serumspecific
IgE antibodies in the diagnosis of immediate
beta-lactam allergy. Allergy 2007;
62:47-52.
39. Bircher AJ, Scherer Hofmeier K. Drug hypersensitivity
reactions: inconsistency in the
use of the classification of immediate and nonimmediate
reactions. J Allergy Clin Immunol
2012;129:263-4.
40. Bousquet PJ, Pipet A, Bousquet-Rouanet
L, Demoly P. Oral challenges are needed in
the diagnosis of beta-lactam hypersensitivity.
Clin Exp Allergy 2008;38:185-90.
41. Blanca M, Romano A, Torres MJ, et al. Update
on the evaluation of hypersensitivity reactions
to betalactams. Allergy 2009;64:183-93.
42. Gomes ER, Demoly P. Epidemiology of hypersensitivity
drug reactions. Curr Opin Allergy
Clin Immunol 2005;5:309-16.
Corrispondenza: e.novembre @meyer.it